(Washington, D.C.) – U.S. Sen. David Vitter today introduced the Ethical Stem Cell Research Tax Credit Act of 2008, which would provide a federal tax credit to entities who conduct stem cell research that does not involve the destruction of – or risk of injury to – human embryos. The bill provides for a tax credit equal to 30 percent of the qualified stem cell research expenses.
“We are only beginning to understand the full potential of adult stem cell research,” said Vitter.
“This research is a source of great hope for so many people who suffer from terrible, degenerative diseases. But we must be responsible in our approach. We should not destroy human embryos when a better, ethical alternative exists in the form of adult stem cells.”
Experimentation on stem cells harvested from human embryos results in the destruction of these embryos during the extraction process. Vitter’s bill seeks to promote the expansion of research programs that utilize adult stem cells as an effective and ethical source for research purposes.
“All human life is precious, whether it is in the beginning stages or the end. Adult stem cell research represents a non-destructive means of preserving human life, and this bill can help further this approach. This sort of medical research can result in significant leaps forward in disease prevention, management and cures while preserving human life in all its stages,” Vitter said.